In Vitro and In Vivo Evaluation of 3D Printed Capsules with Pressure Triggered Release Mechanism for Oral Peptide Delivery

被引:22
作者
Berg, Staffan [1 ,2 ]
Krause, Julius [3 ]
Bjorkbom, Anders [4 ]
Walter, Katrin [5 ]
Harun, Said [2 ]
Granfeldt, Andreas [6 ]
Janzen, David [4 ]
Nunes, Sandro Filipe [7 ]
Antonsson, Malin [7 ]
Van Zuydam, Natalie [8 ]
Skrtic, Stanko [9 ,10 ]
Hugerth, Andreas [11 ]
Weitschies, Werner [3 ]
Davies, Nigel [2 ]
Abrahamsson, Bertil [6 ]
Bergstrom, Christel A. S. [1 ]
机构
[1] Uppsala Univ, Swedish Drug Delivery Ctr, Dept Pharm, BMC POB 580, SE-75123 Uppsala, Sweden
[2] AstraZeneca, R&D, Pharmaceut Sci, Adv Drug Delivery, Gothenburg, Sweden
[3] Ernst Moritz Arndt Univ Greifswald, Dept Biopharmaceut & Pharmaceut Technol, Greifswald, Germany
[4] AstraZeneca, Cardiovasc Renal & Metab BioPharmaceut R&D, Drug Metab & Pharmacokinet, Res & Early Dev, Gothenburg, Sweden
[5] AstraZeneca Gothenburg, Pharmaceut Technol & Dev, Inhalat Prod Dev, Gothenburg, Sweden
[6] AstraZeneca Gothenburg, Operat, Pharmaceut Technol & Dev, Oral Prod Dev, Gothenburg, Sweden
[7] Astrazeneca, Biopharmaceut R&D, Clin Pharmacol & Safety Sci, Anim Sci & Technol, Gothenburg, Sweden
[8] AstraZeneca, BioPharmaceut R&D, Discovery Sci, Data Sci & Quantitat Biol, Gothenburg, Sweden
[9] AstraZeneca, Operat, Pharmaceut Technol & Dev, Innovat Sci & External Liaison, Gothenburg, Sweden
[10] Univ Gothenburg, Sahlgrenska Acad, Dept Internal Med & Clin Nutr, Inst Med, SE-41345 Gothenburg, Sweden
[11] Ferring Pharmaceut AS, Global Pharmaceut R&D, Copenhagen, Denmark
关键词
Oral drug delivery; Permeation enhancer(s); Macromolecular drug delivery; Peptide delivery; Bioavailability; PREDICTING DRUG DISPOSITION; GASTRIC RESIDENCE TIME; INTESTINAL-ABSORPTION; BEAGLE DOGS; PH; BIOAVAILABILITY; PHARMACOKINETICS; OCTREOTIDE; PROFILES; TABLETS;
D O I
10.1016/j.xphs.2020.10.066
中图分类号
R914 [药物化学];
学科分类号
100701 ;
摘要
In this study a 3D printed capsule designed to break from the physiological pressures in the antropyloric region was evaluated for its ability to deliver the synthetic octapeptide octreotide in beagle dogs when co-formulated with the permeation enhancer sodium caprate. The pressure sensitive capsules were compared to traditional enteric coated hard gelatin capsules and enteric coated tablets. Paracetamol, which is completely absorbed in dogs, was included in the formulations and used as an absorption marker to give information about the in vivo performance of the dosage forms. The pressure sensitive capsules released drug in 50% of the dogs. In the cases where drug was released, there was no difference in octreotide bioavailability or C-max compared to the enteric coated dosage forms. When comparing all dosage forms, a correlation was seen between paracetamol C-max and octreotide bioavailability, suggesting that a high drug release rate may be beneficial for peptide absorption when delivered together with sodium caprate. (C) 2020 Published by Elsevier Inc.
引用
收藏
页码:228 / 238
页数:11
相关论文
共 48 条
  • [1] Current status of selected oral peptide technologies in advanced preclinical development and in clinical trials
    Aguirre, T. A. S.
    Teijeiro-Osorio, D.
    Rosa, M.
    Coulter, I. S.
    Alonso, M. J.
    Brayden, D. J.
    [J]. ADVANCED DRUG DELIVERY REVIEWS, 2016, 106 : 223 - 241
  • [2] Gastric pH profiles of beagle dogs and their use as an alternative to human testing
    Akimoto, M
    Nagahata, N
    Furuya, A
    Fukushima, K
    Higuchi, S
    Suwa, T
    [J]. EUROPEAN JOURNAL OF PHARMACEUTICS AND BIOPHARMACEUTICS, 2000, 49 (02) : 99 - 102
  • [3] [Anonymous], 2008, BMC CLIN PHARM
  • [4] Materials for oral delivery of proteins and peptides
    Brown, Tyler D.
    Whitehead, Kathryn A.
    Mitragotri, Samir
    [J]. NATURE REVIEWS MATERIALS, 2020, 5 (02) : 127 - 148
  • [5] CLINICAL PHARMACOKINETICS OF OCTREOTIDE - THERAPEUTIC APPLICATIONS IN PATIENTS WITH PITUITARY-TUMORS
    CHANSON, P
    TIMSIT, J
    HARRIS, AG
    [J]. CLINICAL PHARMACOKINETICS, 1993, 25 (05) : 375 - 391
  • [6] Predicting drug disposition, absorption/elimination/transporter interplay and the role of food on drug absorption
    Custodio, Joseph M.
    Wu, Chi-Yuan
    Benet, Leslie Z.
    [J]. ADVANCED DRUG DELIVERY REVIEWS, 2008, 60 (06) : 717 - 733
  • [7] Effect of absorption-modifying excipients, hypotonicity, and enteric neural activity in an in vivo model for small intestinal transport
    Dahlgren, D.
    Roos, C.
    Lundqvist, A.
    Tannergren, C.
    Sjoblom, M.
    Sjogren, E.
    Lennernas, H.
    [J]. INTERNATIONAL JOURNAL OF PHARMACEUTICS, 2018, 549 (1-2) : 239 - 248
  • [8] Gastrointestinal Tract Disorders in Older Age
    Dumic, Igor
    Nordin, Terri
    Jecmenica, Mladen
    Lalosevic, Milica Stojkovic
    Milosavljevic, Tomica
    Milovanovic, Tamara
    [J]. CANADIAN JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 2019, 2019
  • [9] European Medicines Agency, 2018, EMACHMP3568772017
  • [10] Evonik. Evonik Industries AG, PREC MED EUDR